open access

Vol 28, No 3 (2021)
Editorial
Submitted: 2021-04-14
Accepted: 2021-04-14
Published online: 2021-05-25
Get Citation

Measuring the QT interval on the go

William F. McIntyre1, Carlos A. Morillo2
·
Pubmed: 34046879
·
Cardiol J 2021;28(3):358-359.
Affiliations
  1. Cardiac Electrophysiology and Peri-Operative Medicine Division of Cardiology PhD Candidate, Health Research Methods, McMaster University, Hamilton, Ontario, Canada
  2. Division of Cardiology, Department of Cardiac Sciences, Libin Cardiovascular Institute of Alberta, University of Calgary, Foothills Medical Center, Calgary, Alberta, Canada

open access

Vol 28, No 3 (2021)
Editorial
Submitted: 2021-04-14
Accepted: 2021-04-14
Published online: 2021-05-25

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

Measuring the QT interval on the go

Journal

Cardiology Journal

Issue

Vol 28, No 3 (2021)

Article type

Editorial

Pages

358-359

Published online

2021-05-25

Page views

549

Article views/downloads

599

DOI

10.5603/CJ.2021.0048

Pubmed

34046879

Bibliographic record

Cardiol J 2021;28(3):358-359.

Authors

William F. McIntyre
Carlos A. Morillo

References (7)
  1. Li G, Saguner AM, An J, et al. Cardiovascular disease during the COVID-19 pandemic: Think ahead, protect hearts, reduce mortality. Cardiol J. 2020; 27(5): 616–624.
  2. Abellas-Sequeiros M, Lozano-Granero C, Garcia-Sebastian C, et al. Monitoring of QTc interval in patients with COVID-19. First experience with a portable ECG-recording device. Cardiol J. 2021 [Epub ahead of print].
  3. Horby P, Mafham M, Linsell L, et al. RECOVERY Collaborative Group. Effect of hydroxychloroquine in hospitalized patients with COVID-19. N Engl J Med. 2020; 383(21): 2030–2040.
  4. Cavalcanti AB, Zampieri FG, Rosa RG, et al. Hydroxychloroquine with or without azithromycin in mild-to-moderate COVID-19. N Engl J Med. 2020; 383(21): 2041–2052.
  5. Mitjà O, Corbacho-Monné M, Ubals M, et al. A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of COVID-19. N Engl J Med. 2021; 384(5): 417–427.
  6. Cao B, Wang Y, Wen D, et al. A trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19. N Engl J Med. 2020; 382(19): 1787–1799.
  7. Nachimuthu S, Assar MD, Schussler JM. Drug-induced QT interval prolongation: mechanisms and clinical management. Ther Adv Drug Saf. 2012; 3(5): 241–253.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl